Navigation Links
Dimension AR IMT 220V/50HZ

ProductsDimension AR IMT 220V/50HZ
Company Dade Behring, Inc.
Item Dimension AR IMT 220V/50HZ
Features Dimension AR IMT 220V/50HZ - A mid volume chemistry system with a large on-board capacity and the capability to run over 60 different assays. Features-enhanced efficiency and productivity. Flex-based technology for greater efficiency.
Description Dade Behring's Dimension clinical chemistry integrated systems combine the ease of use of the Flex reagent cartridge, the power of the Multiply and Quicklyte integrated multisensors and the innovation of the heterogeneous module to meet the challenges of your laboratory. Models of innovation and broad test menus, the systems can meet over 97% of your chemistry testing needs on a single workstation.
Info Dade Behring, Inc.Call Dade Behring, Inc. to buy products (US and Canada only; other locations use number below) USACanada1-866-262-8155

Customer Service: 1-847-267-5300
Web site: http://www.dadebehring.com

Related medicine products :

1. Freshlook Dimensions
2. Dimension AR IMT 110V/60HZ
3. Dimension AR IMT 220V/50HZ
4. Dimension RxL Max™ Integrated Chemistry System 50/60HZ
5. Dimension RxL Max™ Integrated Chemistry System
6. Dimension Arx
7. Dimension Xpand Plus Integrated Chemistry System
8. Dimension RxL Max w/HM 50/60HZ
9. Dimension RxL Max w/o HM 50/60 HZ
10. Dimension Xpand
11. DFS Dimension Distal Radius Fixation System
Torso Brief Bodysuit V-BA85
Body Suit w/Bra knee length
Body Suit w/Bra torso
CDIs 2-Panel Abdominal Binders are designed with a foam backing which provides comfort, support and compression without slippage.
Medicine Products:
(Date:12/3/2008)...ear is addition of group health benchmark data pro...d cost for a variety of industries , , SAN ...elp employers evaluate the need for and effectiven...ograms, the non-profit Integrated Benefits Institu...007 benchmarking data. Not only does IBI,s benchma...
(Date:12/3/2008)...IS, Dec. 3 Vertellus Specialties I...announced a price increase of 15-20% effective Jan...all non-contract customers. The price increase is ...production capacity and to provide better supply c... About Vertellus Specialties Inc. , , V...
(Date:12/3/2008)...h Foundation has pledged $975,000 to Burnham Insti...ting-edge stem cell research. The funding, part of...ill support efforts by Dr. Evan Snyder, Stem Cell ..., Director, Center for Neural Repair at the Univer...o treat chronic spinal cord injuries. , "One of ...
(Date:12/3/2008)...udy has found that a school-based asthma education...ol district was shown to reduce symptoms and incre...from asthma were able to go to school. The study w...ool Health . , Nearly 10% or 6.8 million childre...s for Disease Control and Prevention. The problem ...
Breaking Medicine News(10 mins):Health News:Integrated Benefits Institute Announces Availability of 2007 IBI Benchmarking Data for Employers to Evaluate Effectiveness of their Health and Productivity Programs 2Health News:Burnham and HeadNorth Foundation join forces to advance spinal cord research 2Health News:Study shows school-based program enables children and adolescents to better manage chronic disease 2
...to 301 in 2006, the maternal mortality ratio (MMR)...h //has been falling in India, albeit gradually. ...nesday, it hopes to reduce the MMR rate, the numbe...000 live births, to 100 by 2012. Aparajita Gogoi...
...Food and Drug Administration has warned that Ditro...conditions in children and adults// could also cau.... Recommending the institution of clear warnings ...t inadequate warning on the drug could mislead the...
...als may take heart. Their counterparts in the Heal...en blamed for allowing// a fast-food joint swarmin...alth inspector responsible for the “shoddy audit” ...on, which was captured on videotape, created a nat...
... obviously stressed. Who wouldn’t be with a daught...o show her puffing her way through// a mountain of...nne Barlow (née Hunt, formerly Langton and Rachid)...V soap opera Coronation Street. She has been playe...
Other Medicine News:Health News:Ray of Hope for Women on Motherhood Day 2Health News:Officials Indicted for Allowing a Fast Food Joint Teeming With Rats in New York to Function 2Health News:Smoking on Television is Harmful to the Health of the Nation's Youth: BMA 2Health News:Smoking on Television is Harmful to the Health of the Nation's Youth: BMA 3
(Date:12/1/2008)...hosphatasia Treated With ENB-0040 at Children,s Ho..., MONTREAL, Dec. 1 Enobia Pharma...developing novel therapeutics for serious bone dis...ent in its clinical program for hypophosphatasia w...nt Therapy (ERT) with ENB-0040 for the treatment o...
(Date:12/1/2008)...rk, December 1 Following...ntent to procure an MVA-based,third generation s...ces,Canada, on behalf of the Canadian Department ...varian Nordic for the delivery of IMVAMUNE(R). , ...UNE(R) as part of the,country,s bio-preparedness ...
(Date:11/30/2008)... Dec. 1 Older adults wh... flow and a greater number of small blood vessels ...y at the annual meeting of the Radiological Societ...conducted at the University of North Carolina ( ... scans of older adults who exercise to brain scans...
(Date:11/27/2008)...majority of acute lymphoblastic leukemia relapse c... of diagnosis , , MEMPHIS, Tenn., Nov. 27 /...hildren,s Research Hospital have identified distin...ren with acute lymphoblastic leukemia (ALL) that c...gning treatments for ALL relapse in children and, ...
Breaking Medicine Technology:Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 2The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 3Exercise Helps Prevent Age-Related Brain Changes in Older Adults 2Exercise Helps Prevent Age-Related Brain Changes in Older Adults 3St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 3Kiadis Pharma Announces Successful Completion of Rhitol 28TM 29 Phase II Clinical Study 10598 1Atherotech Says Detailed Cholesterol Test Can Help Doctors and Patients Choose Best Therapy 2889 1Atherotech Says Detailed Cholesterol Test Can Help Doctors and Patients Choose Best Therapy 2889 2Atherotech Says Detailed Cholesterol Test Can Help Doctors and Patients Choose Best Therapy 2889 3Bristol Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 10596 1Bristol Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 10596 2Bristol Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 10596 3Bristol Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 10596 4Bristol Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 10596 5Bristol Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 10596 6Bristol Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 10596 7Bristol Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 10596 8Bristol Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 10596 9Bristol Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 10596 10Bristol Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 10596 11Bristol Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 10596 12Bristol Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 10596 13Bristol Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 10596 14Bristol Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 10596 15Bristol Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 10596 16Bristol Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 10596 17Bristol Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 10596 18Bristol Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 10596 19Bristol Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 10596 20Bristol Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 10596 21Bristol Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 10596 22Bristol Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 10596 23Bristol Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 10596 24Bristol Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 10596 25Bristol Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 10596 26Bristol Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 10596 27Bristol Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 10596 28Bristol Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 10596 29Bridges to Excellence Launches Medical Home Program 10592 1Bridges to Excellence Launches Medical Home Program 10592 2Bridges to Excellence Launches Medical Home Program 10592 3Bridges to Excellence Launches Medical Home Program 10592 4
...h Co-Primary Endpoints, Wake After Sleep Onset and...cluding Latency to Persistent,Sleep, Were Met at B...une 04, 2007,/PRNewswire-FirstCall/ -- Evotec AG a...first phase II clinical trial of EVT 201,in patien...tial,positive allosteric modulator (pPAM) of the G...
...CAGO--(BUSINESS WIRE)--Jun 4, 2007 - Genentech, In... a joint analysis of two Phase,III clinical trials...ant treatment of HER2-positive breast cancer. Data...can Society of Clinical,Oncology (ASCO) showed tha...e addition of Herceptin to standard adjuvant thera...
Other Medicine Technology:Evotec Reports Positive Proof-of-Concept Top-Line Results with,Insomnia Drug Candidate EVT 201 2Evotec Reports Positive Proof-of-Concept Top-Line Results with,Insomnia Drug Candidate EVT 201 3Evotec Reports Positive Proof-of-Concept Top-Line Results with,Insomnia Drug Candidate EVT 201 4Updated Overall Survival Data From Pivotal Herceptin Adjuvant,Studies in HER2-Positive Breast Cancer 2Updated Overall Survival Data From Pivotal Herceptin Adjuvant,Studies in HER2-Positive Breast Cancer 3Updated Overall Survival Data From Pivotal Herceptin Adjuvant,Studies in HER2-Positive Breast Cancer 4Updated Overall Survival Data From Pivotal Herceptin Adjuvant,Studies in HER2-Positive Breast Cancer 5Updated Overall Survival Data From Pivotal Herceptin Adjuvant,Studies in HER2-Positive Breast Cancer 6